| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $475.2M | — | +154.4% |
| Cost of Revenue | $452.2M | — | +173.1% |
| Gross Profit | $23.0M | — | +8.7% |
| R&D Expense | $18.5M | — | +7.8% |
| SG&A Expense | $41.8M | — | +14.0% |
| Pre-tax Income | -$70.5M | — | -20.0% |
| Income Tax | -$7.9M | — | -360.0% |
| Net Income | -$45.1M | — | -8.7% |
| EPS (Basic) | -$0.34 | — | -6.3% |
| EPS (Diluted) | -$0.34 | — | -6.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $452.6M | -34.5% | -25.5% |
| Accounts Receivable | $288.9M | +5.9% | +96.6% |
| Inventory | $540.6M | +18.8% | -0.5% |
| Current Assets | $1.99B | -3.8% | +0.2% |
| Total Assets | $2.27B | -3.7% | +2.5% |
| Current Liabilities | $1.34B | -2.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$226.8M | — | -7.4% |
| Capital Expenditures | $5.8M | — | +176.3% |
| Investing Cash Flow | -$9.3M | — | -80.3% |
| Financing Cash Flow | -$1.8M | — | -100.5% |
| Free Cash Flow | -$232.6M | — | -9.0% |
| +6.2% |
| Total Liabilities | $1.78B | -1.5% | +5.7% |
| Stockholders' Equity | $388.0M | -9.7% | -5.2% |